Richard Whitley to Female
This is a "connection" page, showing publications Richard Whitley has written about Female.
Connection Strength
0.807
-
CLINICAL PRACTICE. Genital Herpes. N Engl J Med. 2016 Aug 18; 375(7):666-74.
Score: 0.028
-
Editorial commentary: Waning efficacy of the herpes zoster vaccine. Clin Infect Dis. 2015 Mar 15; 60(6):910-1.
Score: 0.025
-
Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials. Antivir Ther. 2015; 20(7):709-19.
Score: 0.025
-
A novel potential therapy for HSV. N Engl J Med. 2014 Jan 16; 370(3):273-4.
Score: 0.023
-
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2013 May; 56(9):1197-205.
Score: 0.022
-
Changing epidemiology of herpes simplex virus infections. Clin Infect Dis. 2013 Feb; 56(3):352-3.
Score: 0.021
-
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. J Virol. 2012 May; 86(9):5304-13.
Score: 0.021
-
The use of antiviral drugs during the neonatal period. Clin Perinatol. 2012 Mar; 39(1):69-81.
Score: 0.020
-
Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis. Pediatr Infect Dis J. 2011 Oct; 30(10):860-5.
Score: 0.020
-
A 70-year-old woman with shingles: review of herpes zoster. JAMA. 2009 Jul 01; 302(1):73-80.
Score: 0.017
-
Incidence of neonatal herpes simplex virus infections in a managed-care population. Sex Transm Dis. 2007 Sep; 34(9):704-8.
Score: 0.015
-
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S133-8.
Score: 0.014
-
Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006 Nov 01; 43(9):1194-7.
Score: 0.014
-
Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. 2006 Jul; 50(7):2409-14.
Score: 0.014
-
Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates. Vaccine. 2006 Mar 06; 24(10):1644-52.
Score: 0.013
-
Neonatal herpes should be a reportable disease. Sex Transm Dis. 2005 Sep; 32(9):521-5.
Score: 0.013
-
Neonatal herpes: what have we learned. Semin Pediatr Infect Dis. 2005 Jan; 16(1):7-16.
Score: 0.013
-
HSV-2 transmission. Antiviral Res. 2004 Aug; 63 Suppl 1:S27-35.
Score: 0.012
-
Neonatal herpes simplex virus infection. Curr Opin Infect Dis. 2004 Jun; 17(3):243-6.
Score: 0.012
-
Congenital cytomegalovirus infection: epidemiology and treatment. Adv Exp Med Biol. 2004; 549:155-60.
Score: 0.012
-
Vertical mother-to-infant transmission of herpes simplex virus 2 is correlated with tropism due to mutations in viral UL13. J Med Virol. 2024 Jan; 96(1):e29379.
Score: 0.012
-
Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage. 2002 Jun; 23(6):510-6.
Score: 0.010
-
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001 Feb; 20(2):127-33.
Score: 0.010
-
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Hum Gene Ther. 2020 10; 31(19-20):1132-1139.
Score: 0.009
-
Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease. Emerg Infect Dis. 2019 11; 25(11):2064-2073.
Score: 0.009
-
A mixed model for factors predictive of pain in AIDS patients with herpes zoster. J Pain Symptom Manage. 1999 Jun; 17(6):410-7.
Score: 0.009
-
Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population. mSphere. 2019 02 27; 4(1).
Score: 0.008
-
Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999 Jan; 179(1):9-15.
Score: 0.008
-
The identification of risk factors associated with persistent pain following herpes zoster. J Infect Dis. 1998 Nov; 178 Suppl 1:S71-5.
Score: 0.008
-
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother. 1998 May; 42(5):1139-45.
Score: 0.008
-
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997 May; 175(5):1080-6.
Score: 0.007
-
Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol. 1997 Mar; 24(1):267-83.
Score: 0.007
-
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 1996 Sep 01; 125(5):376-83.
Score: 0.007
-
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J. 1996 Mar; 15(3):247-54.
Score: 0.007
-
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis. 2015 Sep 01; 61(5):683-91.
Score: 0.006
-
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis. J Pediatric Infect Dis Soc. 2016 Mar; 5(1):53-62.
Score: 0.006
-
Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics. Clin Infect Dis. 2015 May 01; 60(9):1377-83.
Score: 0.006
-
Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med. 2014 Aug 21; 371(8):711-22.
Score: 0.006
-
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep; 96(3):380-9.
Score: 0.006
-
West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014 May 09; 14:248.
Score: 0.006
-
Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy? Pediatr Infect Dis J. 1994 May; 13(5):432-8; discussion 438-9.
Score: 0.006
-
Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci U S A. 1994 Mar 29; 91(7):2441-7.
Score: 0.006
-
What's the message? A content analysis of newspaper articles about assisted reproductive technology from 2005 to 2011. Hum Fertil (Camb). 2014 Jun; 17(2):124-32.
Score: 0.006
-
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates. Hum Gene Ther Clin Dev. 2014 Mar; 25(1):16-27.
Score: 0.006
-
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. Mol Ther. 2014 May; 22(5):1048-55.
Score: 0.006
-
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest. 1993 Jun; 91(6):2837-43.
Score: 0.006
-
Neonatal herpes simplex virus infections. J Med Virol. 1993; Suppl 1:13-21.
Score: 0.005
-
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013 Mar 01; 207(5):709-20.
Score: 0.005
-
Predictors of undiagnosed herpes simplex virus type 2 seropositivity among persons attending an HIV care clinic. Sex Transm Dis. 2012 Nov; 39(11):857-9.
Score: 0.005
-
Neonatal herpes simplex virus infections: pathogenesis and therapy. Pathol Biol (Paris). 1992 Sep; 40(7):729-34.
Score: 0.005
-
Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant. 2012 Sep; 16(6):627-37.
Score: 0.005
-
Prevalence of herpes simplex virus antibodies in dental students. J Dent Educ. 1992 Mar; 56(3):206-8.
Score: 0.005
-
Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.
Score: 0.005
-
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011 Oct 06; 365(14):1284-92.
Score: 0.005
-
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):444-9.
Score: 0.005
-
Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis. 2010 Aug 15; 202(4):563-6.
Score: 0.005
-
Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol. 1990 Jun; 47(6):646-7.
Score: 0.005
-
Reference values in pediatric medicine. Mayo Clin Proc. 1990 Mar; 65(3):431-5.
Score: 0.004
-
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J. 2010 Mar; 29(3):195-8.
Score: 0.004
-
Novel pharmacological strategies in the treatment of life-threatening cytomegalovirus infections. Clinical experience with continuous infusion 9-(1,3-dihydroxy-2-propoxymethyl) guanine. Ann N Y Acad Sci. 1990; 616:452-60.
Score: 0.004
-
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec; 46 Suppl 4:S22-6.
Score: 0.004
-
Intrauterine herpes simplex virus infection. Teratology. 1989 Jan; 39(1):1-10.
Score: 0.004
-
Neonatal herpes simplex virus infections. Clin Perinatol. 1988 Dec; 15(4):903-16.
Score: 0.004
-
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther. 2009 Jan; 17(1):199-207.
Score: 0.004
-
Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl. 2008 Oct; 14(10):1498-504.
Score: 0.004
-
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis. 1988 Jul; 158(1):109-16.
Score: 0.004
-
Isolated Cryptococcus neoformans osteomyelitis in an immunocompetent child. Pediatr Infect Dis J. 1988 Apr; 7(4):289-92.
Score: 0.004
-
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008 Mar 15; 197(6):836-45.
Score: 0.004
-
Condylomata acuminata in IDDM. Diabetes Care. 1988 Mar; 11(3):295-6.
Score: 0.004
-
Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins. Intervirology. 1988; 29(1):39-49.
Score: 0.004
-
Natural history and pathogenesis of neonatal herpes simplex virus infections. Ann N Y Acad Sci. 1988; 549:103-17.
Score: 0.004
-
Antiviral treatment of a serious herpes simplex infection: encephalitis. J Am Acad Dermatol. 1988 Jan; 18(1 Pt 2):209-11.
Score: 0.004
-
Condyloma acuminatum: epidemiological, clinical and therapeutic aspects. Eur J Epidemiol. 1987 Sep; 3(3):209-15.
Score: 0.004
-
HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice. Vaccine. 2007 Sep 17; 25(37-38):6764-73.
Score: 0.004
-
Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity. J Clin Immunol. 1987 Jul; 7(4):304-11.
Score: 0.004
-
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun; 81(6):867-72.
Score: 0.004
-
Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract. 2007 Jan; 56(1):30-6.
Score: 0.004
-
Protective immunity against herpetic ocular disease in an outbred mouse model. Curr Eye Res. 1987 Jan; 6(1):167-71.
Score: 0.004
-
Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease. Curr Eye Res. 1987 Jan; 6(1):173-7.
Score: 0.004
-
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis. 2007 Jan 15; 44(2):245-9.
Score: 0.004
-
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors. Cancer Gene Ther. 2007 Jan; 14(1):45-56.
Score: 0.004
-
Neonatal herpes simplex virus infections. Presentation and management. J Reprod Med. 1986 May; 31(5 Suppl):426-32.
Score: 0.003
-
Analysis of DNA from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion. Sex Transm Dis. 1986 Apr-Jun; 13(2):61-6.
Score: 0.003
-
Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol. 2006 Mar; 194(3):774-81.
Score: 0.003
-
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16; 314(3):144-9.
Score: 0.003
-
Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections. N Engl J Med. 1985 Nov 21; 313(21):1327-30.
Score: 0.003
-
Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985 Nov 14; 313(20):1270-4.
Score: 0.003
-
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl. 2005 Aug; 11(8):941-9.
Score: 0.003
-
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12. Cancer Gene Ther. 2005 Apr; 12(4):359-68.
Score: 0.003
-
Therapeutic challenges of neonatal herpes simplex virus infection. Scand J Infect Dis Suppl. 1985; 47:97-106.
Score: 0.003
-
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004 Nov 01; 39(9):1307-13.
Score: 0.003
-
Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis. 1984 Sep; 150(3):323-9.
Score: 0.003
-
Treatment of human herpesvirus infections with special reference to encephalitis. J Antimicrob Chemother. 1984 Aug; 14 Suppl A:57-74.
Score: 0.003
-
Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J Infect Dis. 1984 Jan; 149(1):1-8.
Score: 0.003
-
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics. 1983 Dec; 72(6):778-85.
Score: 0.003
-
Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir. J Antimicrob Chemother. 1983 Sep; 12 Suppl B:105-12.
Score: 0.003
-
Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy. 1983 Sep-Oct; 3(5):275-83.
Score: 0.003
-
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003 Jul; 143(1):16-25.
Score: 0.003
-
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. 2003 Apr; 22(4):335-41.
Score: 0.003
-
Towards therapy and prevention of herpetic infections. Semin Perinatol. 1983 Jan; 7(1):64-81.
Score: 0.003
-
Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982 Oct 21; 307(17):1060-2.
Score: 0.003
-
Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med. 1982 Oct 14; 307(16):971-5.
Score: 0.003
-
Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med. 1982 Jul 20; 73(1A):236-40.
Score: 0.003
-
Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr. 1982 Jul; 101(1):125-31.
Score: 0.003
-
Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982 Jan 15; 247(3):317-20.
Score: 0.003
-
The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980 Oct; 66(4):489-94.
Score: 0.002
-
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A. 2000 Feb 29; 97(5):2208-13.
Score: 0.002
-
Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr Infect Dis J. 1999 Oct; 18(10):869-74.
Score: 0.002
-
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus. Clin Cancer Res. 1999 Jun; 5(6):1517-22.
Score: 0.002
-
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol. 1998 Oct; 179(4):846-51.
Score: 0.002
-
Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol. 1998 Aug; 36(8):2229-34.
Score: 0.002
-
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11; 297(6):289-94.
Score: 0.002
-
Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection. J Pediatr. 1976 Jul; 89(1):16-22.
Score: 0.002
-
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9.
Score: 0.002
-
Neonatal herpes simplex virus infection. Int Ophthalmol Clin. 1975; 15(4):141-9.
Score: 0.002
-
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med. 1993 Oct 07; 329(15):1065-72.
Score: 0.001
-
The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis. 1992 Dec; 15(6):1031-8.
Score: 0.001
-
Transmission of herpes simplex virus type 1 infection in an intensive care unit. Ann Intern Med. 1992 Oct 01; 117(7):584-6.
Score: 0.001
-
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr. 1992 Apr; 120(4 Pt 1):627-33.
Score: 0.001
-
A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med. 1991 Nov 28; 325(22):1539-44.
Score: 0.001
-
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus). J Infect Dis. 1990 Aug; 162(2):313-21.
Score: 0.001
-
Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet. 1990 Feb 24; 335(8687):440-1.
Score: 0.001
-
Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. Am J Med. 1988 Sep; 85(3):301-6.
Score: 0.001
-
Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial. Ann Intern Med. 1988 May; 108(5):675-9.
Score: 0.001
-
Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells. J Immunol. 1987 Feb 15; 138(4):1229-33.
Score: 0.001
-
T-cell imbalances and NK activity in varicella-zoster virus infections. Viral Immunol. 1987; 1(2):145-52.
Score: 0.001
-
Diagnosis of viral encephalitis by brain biopsy. Semin Diagn Pathol. 1984 May; 1(2):71-81.
Score: 0.001
-
Prophylactic or anticipatory antiviral therapy for newborns exposed to herpes simplex infection. Pediatr Infect Dis. 1984 May-Jun; 3(3):193-5.
Score: 0.001
-
Repeated suppression of Creutzfeldt-Jakob disease with vidarabine. Lancet. 1982 Sep 04; 2(8297):564-5.
Score: 0.001
-
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics. 1981 Sep; 68(3):322-9.
Score: 0.001
-
Herpes zoster in early infancy. Am J Dis Child. 1980 Jun; 134(6):618-9.
Score: 0.001
-
Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther. 1979 Dec; 26(6):718-28.
Score: 0.001
-
Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis. 1979 Oct; 140(4):487-92.
Score: 0.001
-
Outcome of renal transplantation in patients with primary cytomegalovirus infection. Transplant Proc. 1979 Jun; 11(2):1288-90.
Score: 0.001
-
Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics. 1975 May; 55(5):678-85.
Score: 0.000
-
Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis. 1974 Jul; 130(1):32-9.
Score: 0.000
-
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis. 1973 Nov; 128(5):658-63.
Score: 0.000